The Week Ahead: Hom...
Health Care: Drugs
Meridian Bioscience Inc. (VIVO: NASDAQ)
$22.01 0.31 | 1.43%
05/17/13 - 04:00 PM ET
Company Cash Flow
| Sep 2012 | Sep 2011 | Sep 2010 | Sep 2009 | |
| Cash Flow From Operating Activities | ||||
|---|---|---|---|---|
| Net Income (Loss) | 33.37M | 26.83M | 26.65M | 32.76M |
| Operating Gains/Losses | 359.00K | 446.00K | 26.00K | 109.00K |
| Extraordinary Gains / Losses | 0.00 | 0.00 | 0.00 | 0.00 |
| (Increase) Decrease In Receivables | 0.00 | 0.00 | 0.00 | -5.35M |
| (Increase) Decrease in Inventories | 0.00 | 0.00 | 0.00 | 0.00 |
| (Increase) Decrease In Other Current Assets | 1.23M | -10.76M | 3.68M | 0.00 |
| (Decrease) Increase In Payables | 0.00 | 0.00 | 0.00 | 269.00K |
| (Decrease) Increase In Other Current Liabilities | 3.22M | -570.00K | -5.78M | 0.00 |
| (Increase) Decrease In Other Working Capital | 0.00 | -648.00K | 74.00K | -234.00K |
| Other Non-Cash Items | -883.00K | 2.50M | 1.87M | 1.08M |
| Net Cash From Continuing Operations | 42.45M | 22.46M | 31.21M | 32.49M |
| Net Cash From Discontinued Operations | 0.00 | 0.00 | 0.00 | 0.00 |
| Cash Provided By Investing Activities | ||||
| Net Cash From Total Operating Activities | 42.45M | 22.46M | 31.21M | 32.49M |
| Sale of Property, Plant & Equipment | 400.00K | 0.00 | 0.00 | 5.00K |
| Cash Used for Investing Activities | ||||
| Sale of Short-Term Investments | 0.00 | 0.00 | 7.28M | 0.00 |
| Purchases of Property, Plant & Equipment | -4.84M | -9.15M | -4.68M | -3.75M |
| Acquisitions | 0.00 | 0.00 | -20.40M | -7.00K |
| Purchases of Short-Term Investments | 0.00 | 0.00 | 0.00 | 0.00 |
| Other Cash from Investing Activities | 0.00 | 0.00 | 0.00 | 0.00 |
| Cash Provided by Financing Activities | ||||
| Net Cash From Investing Activities | -4.44M | -9.15M | -17.81M | -3.28M |
| Issuance of Debt | 0.00 | 0.00 | 0.00 | 0.00 |
| Cash Used for Financing Activities | ||||
| Issuance of Capital Stock | 552.00K | 3.42M | 795.00K | 1.62M |
| Repayment of Long-Term Debt | 0.00 | 0.00 | 0.00 | 0.00 |
| Repurchase of Capital Stock | 0.00 | 0.00 | 0.00 | 0.00 |
| Payment of Cash Dividends | -31.23M | -30.94M | -29.98M | -26.26M |
| Other Financing Charges, Net | 0.00 | 0.00 | 0.00 | 0.00 |
| Net Cash From Financing Activities | -30.67M | -27.52M | -29.19M | -24.64M |
| Effect of Exchange Rate Changes | 630.00K | -38.00K | -362.00K | 157.00K |
| Net Change in Cash & Cash Equivalents | 7.97M | -14.25M | -16.15M | 4.73M |
Portfolios with VIVO
- Portfolio NameUser Type
- ContributorStocks Rising On Unusual Vo...
- ContributorHighest-Yielding Drug Stocks
- Userhulkkims Portfolio 1
- ContributorBarron's Insider Purchases ...
- UserSUPRATRADE 20 Dividend Stoc...
- UserSUPRATRADE HOT STOCKS (BUY ...
- ContributorDividend Stocks for the Wee...
- Userrussbow98 Portfolio 1
- ContributorBarron's Insider Purchases ...
- ContributorBarron's Insider Purchases ...
Latest VIVO Headlines from TheStreet
- Meridian Bioscience Inc. Stock Upgraded (VIVO) 10.15.12 | 05:10 am
- Meridian Bioscience Inc. Stock Downgraded (VIVO) 08.22.12 | 05:08 am
- Meridian Bioscience Stock To Go Ex-dividend Tomorrow (VIVO) 05.01.12 | 09:05 am
- 8 Stocks Rising on Huge Volume 04.20.12 | 01:04 pm
- Meridian Bioscience Inc. Stock Upgraded (VIVO) 03.29.12 | 05:03 am
- Meridian Bioscience Rises On Unusually High Volume (VIVO) 02.01.12 | 03:02 pm
- Meridian Bioscience Stock To Go Ex-dividend Tomorrow (VIVO) 01.31.12 | 09:01 am
- Meridian Bioscience Stock To Go Ex-dividend Tomorrow (VIVO) 11.16.11 | 10:11 am
- Meridian Bioscience Stock Hits New 52-Week Low (VIVO) 10.03.11 | 09:10 am
- Meridian Bioscience Stock Hits New 52-Week Low (VIVO) 09.21.11 | 02:09 pm
Press Releases for VIVO
- Meridian Bioscience Recognized By Forbes As One Of America’s 100 Most Trustworthy Companies - Business Wire 03.28.13 | 11:03 am
- Meridian Bioscience Announces Illumigene® Group A Streptococcus And Illumigene® Group B Streptococcus Tests Categorized “Moderate Complexity” By FDA - Business Wire 03.18.13 | 11:03 am
- Bioline Launches ISOLATE II, A Precious Find For DNA And RNA Isolation - Business Wire 02.06.13 | 07:02 am
- Meridian Bioscience Reports First Quarter 2013 Operating Results And Reaffirms Fiscal 2013 Guidance - Business Wire 01.23.13 | 07:01 am
- Meridian Bioscience Successfully Completes Beta Trials For Two New Illumigene® Tests - Business Wire 12.13.12 | 02:12 pm
- Meridian Bioscience, Inc. Declares Regular Quarterly Dividend And Accelerates Payment Date To December 24, 2012 - Business Wire 12.04.12 | 10:12 am
- SensiFAST™ Genotyping Kit Exceed The Limit - Business Wire 11.28.12 | 07:11 am
- Meridian Bioscience Reports Fourth Quarter And Full-Year 2012 Operating Results, Declares Regular Cash Dividend, And Reaffirms Fiscal 2013 Guidance - Business Wire 11.08.12 | 07:11 am
- Meridian Bioscience Receives FDA Clearance For New Molecular Test: Illumigene® Group A Strep - Business Wire 09.17.12 | 03:09 pm
- Meridian Bioscience Provides Sales And Earnings Guidance For Fiscal 2013 And Reaffirms Fiscal 2012 Guidance - Business Wire 08.28.12 | 07:08 am
Partner Headlines for VIVO
- FDA Clears Meridian Ilumigene GAS - Analyst Blog - NASDAQ 09.20.12 | 04:09 pm
- Gilead REITERATED a Top Pick and 4 Stock Analyses Trending Now - Wall St. Cheat Sheet 07.27.12 | 12:07 pm
- Starbucks DOWNGRADED to Neutral and 4 Downgraded Shares Attracting Attention - Wall St. Cheat Sheet 07.27.12 | 03:07 am
- Meridian Bioscience Receives FDA Clearance for New Legionella Test - Benzinga 02.27.12 | 01:02 pm
- UPDATE: Wedbush Downgrades Meridian Bioscience to Underperform - Benzinga 01.31.12 | 09:01 am
- Dividend Stocks That Combine Growth And Income - Seeking Alpha 01.20.12 | 08:01 am
- FDA OKs Meridian's GDH Test - Analyst Blog - Zacks 01.05.12 | 10:01 am
- 30 'Overdue' Dividend Increases -- Will History Repeat Itself? - Seeking Alpha 08.19.11 | 06:08 pm
- FDA OKs Meridian C. difficile Test - Analyst Blog - Zacks 05.13.11 | 09:05 am
- Meridian Bioscience: An Overvalued Dividend Contender - Seeking Alpha 04.12.11 | 06:04 am
